SNY (Sanofi) Market Cap : $120,320 Mil (As of Dec. 12, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Sanofi Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sanofi's share price for the quarter that ended in Jun. 2024 was $48.52. Sanofi's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 2,502 Mil. Therefore, Sanofi's market cap for the quarter that ended in Jun. 2024 was $121,400 Mil.

Sanofi's quarterly market cap declined from Jun. 2023 ($134,910 Mil) to Dec. 2023 ($124,459 Mil) and declined from Dec. 2023 ($124,459 Mil) to Jun. 2024 ($121,400 Mil).

Sanofi's annual market cap declined from Dec. 2021 ($125,505 Mil) to Dec. 2022 ($122,124 Mil) but then increased from Dec. 2022 ($122,124 Mil) to Dec. 2023 ($124,459 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sanofi's Enterprise Value for Today is $138,486 Mil.

Sanofi Market Cap Historical Data

The historical data trend for Sanofi's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Market Cap Chart

Sanofi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

125,884.03

121,542.05

125,504.51

122,124.48

124,459.27

Sanofi Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Market Cap	Get a 7-Day Free Trial															125,275.12	122,124.48	134,910.08	124,459.27	121,399.95

Competitive Comparison of Sanofi's Market Cap

For the Drug Manufacturers - General subindustry, Sanofi's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sanofi's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi's Market Cap distribution charts can be found below:

* The bar in red indicates where Sanofi's Market Cap falls into.

Sanofi Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Sanofi's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$49.73	*	2502.7
	=	$124,459

Sanofi's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )	=	Share Price (Q: Jun. 2024 )	*	Shares Outstanding (EOP) (Q: Jun. 2024 )
	=	$48.52	*	2502.06
	=	$121,400

Sanofi (NAS:SNY) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Sanofi Market Cap Related Terms

Thank you for viewing the detailed overview of Sanofi's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:Mexico 1SAN:Italy SANp:UK 0O59:UK SAN:France SNW:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SNW:Bulgaria SANO:Austria

Address

46, avenue de la Great Army, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.